Nutroganics, Inc.
Other OTCTotal Valuation
Nutroganics, Inc. carries a market capitalization of 1.07M, placing it among publicly traded companies globally. Its enterprise value stands at 3.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.07M |
| Enterprise Value | 3.36M |
Share Statistics
Nutroganics, Inc. currently has 7.11M shares outstanding.
| Shares Outstanding | 7.11M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Nutroganics, Inc. trades at a trailing price-to-earnings ratio of 30.23. The price-to-sales ratio is 0.60, and the price-to-book ratio stands at -0.15.
| PE Ratio | 30.23 |
| PS Ratio | 0.60 |
| PB Ratio | -0.15 |
| P/TBV Ratio | -5.77 |
| P/FCF Ratio | -52.70 |
| P/OCF Ratio | -34.73 |
Enterprise Valuation
On an enterprise value basis, Nutroganics, Inc. trades at an EV/EBITDA multiple of 12.63 and an EV/FCF ratio of 45.11. The EV/Sales ratio of 0.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.66 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.66 |
| EV / EBITDA | 12.63 |
| EV / EBIT | 30.66 |
| EV / FCF | 45.11 |
Financial Position
Nutroganics, Inc. maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.03 |
| Quick Ratio | 0.87 |
| Debt / Equity | -141.51 |
| Debt / EBITDA | 2.82 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -21.43 |
| Return on Invested Capital (ROIC) | 259.36 |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 11.37 |
Income Statement
Over the trailing twelve months, Nutroganics, Inc. generated 5.07M in revenue and converted that into -390,000.00 in net income, yielding earnings per share of -0.05. EBITDA reached 266,000.00, while operating income came in at -26,000.00.
| Revenue | 5.07M |
| Gross Profit | 3.17M |
| Operating Income | -26,000.00 |
| Pretax Income | -390,000.00 |
| Net Income | -390,000.00 |
| EBITDA | 266,000.00 |
| EBIT | -26,000.00 |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
Nutroganics, Inc. holds 446,000.00 in cash and equivalents against 750,000.00 in total debt, resulting in a net debt position of 304,000.00. Total book value stands at -20.56M, with working capital of 50,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 446,000.00 |
| Total Debt | 750,000.00 |
| Net Debt | 304,000.00 |
| Equity (Book Value) | -20.56M |
| Book Value Per Share | -2.89 |
| Working Capital | 50,000.00 |
Cash Flow
Nutroganics, Inc. produced -88,000.00 in operating cash flow over the past twelve months. After subtracting -30,000.00 in capital expenditures, free cash flow totaled -118,000.00 - equivalent to -0.02 per share.
| Operating Cash Flow | -88,000.00 |
| Capital Expenditures | -30,000.00 |
| Free Cash Flow | -118,000.00 |
| FCF Per Share | -0.02 |
Margins
Nutroganics, Inc. operates with a gross margin of 62.53, reflecting its pricing power and cost economics. The operating margin of -0.51 and net profit margin of -7.70 provide insight into operational efficiency.
| Gross Margin | 62.53 |
| Operating Margin | -0.51 |
| Pretax Margin | -7.70 |
| Profit Margin | -7.70 |
| EBITDA Margin | 5.25 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.20 |
| FCF Yield | -1.90 |
Scores
Nutroganics, Inc. posts an Altman Z-Score of -11.97, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -11.97 |